Skip to main content

Table 4 Comparison of prognosis between drug-sensitive group and control group

From: Clinical application of drug sensitive gene detection in postoperative instillation for non-muscle invasive bladder cancer

  

Drug sensitive group (N = 44)

Control group

(N = 254)

χ2/t

P value

Relapse

Rate

11.36%(5/44)

37.40%(95/254)

11.404

0.010

Metastasis

Rate

4.54%(2/44)

3.14%(8/254)

0.225

0.635

 

Time (month)

20.00 ± 2.83

27.85 ± 12.10

2.263

0.406

Death

Rate

6.81%(3/44)

7.48%(19/254)

1.265

0.809

 

Time (month)

22.00 ± 3.46

23.33 ± 9.01

0.024

0.877